{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:42:14Z","timestamp":1784212934959,"version":"3.55.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.canlet.2024.217279","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T16:29:56Z","timestamp":1727368196000},"page":"217279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma"],"prefix":"10.1016","volume":"605","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3313-0894","authenticated-orcid":false,"given":"Faye","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Beirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cadoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin\u00e9ad","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Kanjuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"O'Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Gately","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Oner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volga M.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Selemidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Haughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras Abu","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-7246","authenticated-orcid":false,"given":"Mark P.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-9326","authenticated-orcid":false,"given":"John J.","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9260-3225","authenticated-orcid":false,"given":"Sharon A.","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib1","doi-asserted-by":"crossref","first-page":"e936","DOI":"10.1002\/hsr2.936","article-title":"The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer","volume":"5","author":"Mazidimoradi","year":"2022","journal-title":"Health Sci Rep."},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2024.217279_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061823","article-title":"CA-125 early dynamics to predict overall survival in women with newly diagnosed advanced ovarian cancer based on meta-analysis data","volume":"15","author":"Karamouza","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217279_bib6","first-page":"146","article-title":"A case of cancer in which cells similar to those in the tumors were seen in the blood after death","volume":"14","author":"Ashworth","year":"1869","journal-title":"Australian Med J"},{"issue":"11","key":"10.1016\/j.canlet.2024.217279_bib7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","article-title":"Better together: circulating tumor cell clustering in metastatic cancer","volume":"7","author":"Schuster","year":"2021","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2024.217279_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib9","first-page":"23","article-title":"Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation","volume":"63","author":"Resel Folkersma","year":"2010","journal-title":"Arch. Esp. Urol."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2024.217279_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-010-0115-3","article-title":"Circulating tumor cells in colorectal cancer: past, present, and future challenges","volume":"11","author":"Negin","year":"2010","journal-title":"Curr. Treat. Options Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","article-title":"Clinical implications of intratumor heterogeneity: challenges and opportunities","volume":"98","author":"Ram\u00f3n","year":"2020","journal-title":"J Mol Med (Berl)."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.20892\/j.issn.2095-3941.2016.0024","article-title":"Genetic and molecular changes in ovarian cancer","volume":"13","author":"Hollis","year":"2016","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11040697","article-title":"What is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors","volume":"11","author":"De Leo","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.canlet.2024.217279_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2017.06.007","article-title":"Ovarian cancer: novel molecular aspects for clinical assessment","volume":"117","author":"Palmirotta","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"16","key":"10.1016\/j.canlet.2024.217279_bib15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.217279_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/OTT.S272199","article-title":"Ovarian cancer therapy: homologous recombination deficiency as a predictive biomarker of response to PARP inhibitors","volume":"15","author":"Miller","year":"2022","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oncolo\/oyab053","article-title":"Homologous recombination deficiency: concepts, definitions, and assays","volume":"27","author":"Stewart","year":"2022","journal-title":"Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41588-023-01320-2","article-title":"Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer","volume":"55","author":"Burdett","year":"2023","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41591-019-0593-1","article-title":"Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse","volume":"25","author":"Chemi","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib20","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/s41598-023-29416-z","article-title":"Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients","volume":"13","author":"Asante","year":"2023","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.canlet.2024.217279_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246225","article-title":"Multi-marker immunofluorescent staining and PD-L1 detection on circulating tumour cells from ovarian cancer patients","volume":"13","author":"Asante","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","article-title":"Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?","volume":"20","author":"Ward","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib23","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1038\/s41467-022-31009-9","article-title":"High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells","volume":"13","author":"Boya","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2017.02.042","article-title":"Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer","volume":"145","author":"Lee","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib25","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051111","article-title":"Analysis of a real-world cohort of metastatic breast cancer patients shows circulating tumor cell clusters (CTC-clusters) as predictors of patient outcomes","volume":"12","author":"Costa","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051149","article-title":"Highly correlated recurrence prognosis in patients with metastatic colorectal cancer by synergistic consideration of circulating tumor cells\/microemboli and tumor markers CEA\/CA19-9","volume":"10","author":"Chu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2024.217279_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2023.07.011","article-title":"The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment","volume":"263","author":"Hao","year":"2024","journal-title":"Transl. Res."},{"issue":"18","key":"10.1016\/j.canlet.2024.217279_bib29","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-16-2072","article-title":"Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers","volume":"77","author":"Murlidhar","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020268","article-title":"Improved prognostic stratification using circulating tumor cell clusters in patients with metastatic castration-resistant prostate cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.canlet.2024.217279_bib32","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1158\/1078-0432.CCR-19-0208","article-title":"Circulating tumor cell clusters in patients with metastatic breast cancer: a SWOG S0500 translational medicine study","volume":"25","author":"Paoletti","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.canlet.2024.217279_bib33","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217279_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5306\/wjco.v11.i11.868","article-title":"Liquid biopsy in ovarian cancer: catching the silent killer before it strikes","volume":"11","author":"Feeney","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217279_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","article-title":"New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination","volume":"175","author":"Coffman","year":"2016","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2024.217279_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mehy.2017.11.006","article-title":"The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions","volume":"110","author":"Garavaglia","year":"2018","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13000-021-01079-2","article-title":"Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics","volume":"16","author":"Dundr","year":"2021","journal-title":"Diagn. Pathol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib42","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1002\/cam4.1741","article-title":"Role of tumor microenvironment in the pathobiology of ovarian cancer: insights and therapeutic opportunities","volume":"7","author":"Ghoneum","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.217279_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1159061","article-title":"CXCL8 and the peritoneal metastasis of ovarian and gastric cancer","volume":"14","author":"Fu","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2024.217279_bib45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","article-title":"Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression","volume":"103","author":"Jiang","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/ijms14012085","article-title":"Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9\/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening","volume":"14","author":"Laios","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib48","first-page":"605","article-title":"In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors","volume":"23","author":"Roomi","year":"2010","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0497-3","article-title":"Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?","volume":"15","author":"Bekes","year":"2016","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2024.217279_bib51","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib52","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3802\/jgo.2020.31.e67","article-title":"Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis","volume":"31","author":"Chiyoda","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10585-021-10123-w","article-title":"The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis","volume":"39","author":"Leong","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2024.217279_bib55","first-page":"17","article-title":"Pelviperineal venous insufficiency and varicose veins of the lower limbs","volume":"5","author":"Balian","year":"2008","journal-title":"Phlebolymphology"},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111597","article-title":"\"Sentinel\" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease","volume":"9","author":"Ilie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217279_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","article-title":"Circulating tumour cells for early detection of clinically relevant cancer","volume":"20","author":"Lawrence","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib58","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae022","article-title":"Dissemination of circulating tumor cells in breast and prostate cancer: implications for early detection","volume":"165","author":"Bae","year":"2024","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib59","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm1095-1035","article-title":"Individual development and uPA\u2013receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer","volume":"1","author":"Heiss","year":"1995","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.canlet.2024.217279_bib60","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","article-title":"Circulating tumor cells in patients with breast cancer dormancy","volume":"10","author":"Meng","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-mesenchymal transition in cancer: a historical overview","volume":"13","author":"Ribatti","year":"2020","journal-title":"Transl Oncol"},{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060838","article-title":"The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance","volume":"11","author":"Loret","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A collagen-remodeling gene signature regulated by TGF-\u03b2 signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"19","key":"10.1016\/j.canlet.2024.217279_bib66","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1373\/clinchem.2018.287102","article-title":"Circulating tumor cells in prostate cancer: from discovery to clinical utility","volume":"65","author":"Pantel","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2024.217279_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/617421","article-title":"Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer","volume":"2010","author":"Miller","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.canlet.2024.217279_bib69","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/OTT.S307546","article-title":"Artificial intelligence based on blood biomarkers including CTCs predicts outcomes in epithelial ovarian cancer: a prospective study","volume":"14","author":"Ma","year":"2021","journal-title":"OncoTargets Ther."},{"issue":"7","key":"10.1016\/j.canlet.2024.217279_bib70","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.18632\/oncotarget.23943","article-title":"Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer","volume":"9","author":"Guo","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib71","doi-asserted-by":"crossref","first-page":"812","DOI":"10.18632\/oncotarget.22549","article-title":"Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells","volume":"9","author":"Obermayr","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217279_bib72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: ready for prime time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tjog.2021.11.008","article-title":"Circulating tumor cells as a \u201creal-time liquid biopsy\u201d: recent advances and the application in ovarian cancer","volume":"61","author":"Jou","year":"2022","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.canlet.2024.217279_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415979","article-title":"Technologies for viable circulating tumor cell isolation","volume":"23","author":"Tretyakova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib75","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1596\/neo.12696","article-title":"Sensitive and direct detection of circulating tumor cells by multimarker \u03bc-nuclear magnetic resonance","volume":"14","author":"Ghazani","year":"2012","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.canlet.2024.217279_bib76","first-page":"9599","article-title":"Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system","volume":"10","author":"Rao","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217279_bib77","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/ijc.23717","article-title":"Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands","volume":"123","author":"He","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10040249","article-title":"Circulating tumor cells enumerated by a centrifugal microfluidic device as a predictive marker for monitoring ovarian cancer treatment: a pilot study","volume":"10","author":"Kim","year":"2020","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib79","doi-asserted-by":"crossref","DOI":"10.1063\/1.4731647","article-title":"ApoStream(\u2122), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood","volume":"6","author":"Gupta","year":"2012","journal-title":"Biomicrofluidics"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib80","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Aktas","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib81","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00404-020-05477-7","article-title":"Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer","volume":"301","author":"Banys-Paluchowski","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5858\/arpa.2016-0483-OA","article-title":"Effect of blood collection tube type and time to processing on the enumeration and high-content characterization of circulating tumor cells using the high-definition single-cell assay","volume":"142","author":"Rodr\u00edguez-Lee","year":"2018","journal-title":"Arch. Pathol. Lab Med."},{"issue":"7917","key":"10.1016\/j.canlet.2024.217279_bib83","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41586-022-04875-y","article-title":"The metastatic spread of breast cancer accelerates during sleep","volume":"607","author":"Diamantopoulou","year":"2022","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.canlet.2024.217279_bib84","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1200\/JCO.2010.28.2764","article-title":"Circulating tumor cells and sample size: the more, the better","volume":"28","author":"Lalmahomed","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217279_bib85","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1073\/pnas.95.8.4589","article-title":"Detection and characterization of carcinoma cells in the blood","volume":"95","author":"Racila","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib86","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/ijc.31752","article-title":"Toward a real liquid biopsy in metastatic breast and prostate cancer: diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)","volume":"143","author":"Andree","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41416-021-01634-0","article-title":"Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival","volume":"126","author":"Tamminga","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217279_bib88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2021.03.023","article-title":"Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells","volume":"150","author":"Mout","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-024-01984-2","article-title":"Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells","volume":"23","author":"Rieckmann","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib90","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1038\/s41598-023-30733-6","article-title":"Ex vivo expansion of circulating tumour cells (CTCs)","volume":"13","author":"Mohamed","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2024.217279_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061213","article-title":"Advancements in circulating tumor cell research: bridging biology and clinical applications","volume":"16","author":"Salu","year":"2024","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.canlet.2024.217279_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112668","article-title":"Short-term ex vivo culture of CTCs from advance breast cancer patients: clinical implications","volume":"13","author":"Carmona-Ule","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib93","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/0008-5472.CAN-14-2613","article-title":"Establishment and characterization of a cell line from human circulating colon cancer cells","volume":"75","author":"Cayrefourcq","year":"2015","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/bph.14542","article-title":"Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics","volume":"176","author":"Lallo","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105081","article-title":"Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine","volume":"25","author":"Chen","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2024.217279_bib96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2407-12-178","article-title":"Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition","volume":"12","author":"Gorges","year":"2012","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cyto.b.20573","article-title":"External quality assurance of circulating tumor cell enumeration using the CellSearch(\u00ae) system: a feasibility study","volume":"80","author":"Kraan","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"issue":"16","key":"10.1016\/j.canlet.2024.217279_bib98","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/s41388-017-0106-y","article-title":"Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype","volume":"37","author":"Akhter","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-024-01789-1","article-title":"Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41416-022-01768-9","article-title":"Circulating tumour cells in the -omics era: how far are we from achieving the \u2018singularity\u2019","volume":"127","author":"Visal","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib101","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41416-022-01962-9","article-title":"Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer","volume":"127","author":"Fernandez-Garcia","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2024.217279_bib102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ijgc-2023-004924","article-title":"Mirvetuximab soravtansine-gynx: first antibody\/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer","volume":"34","author":"Bogani","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.canlet.2024.217279_bib103","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.2147\/CMAR.S211455","article-title":"Circulating tumor cell detection in epithelial ovarian cancer using dual-component antibodies targeting EpCAM and FR\u03b1","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217279_bib104","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41416-023-02428-2","article-title":"Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping","volume":"129","author":"Payne","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib105","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1739\/aaa013","article-title":"Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry","volume":"4","author":"Gerdtsson","year":"2018","journal-title":"Converg Sci Phys Oncol"},{"issue":"5","key":"10.1016\/j.canlet.2024.217279_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051218","article-title":"Circulating tumor cells characterization revealed TIMP1 as a potential therapeutic target in ovarian cancer","volume":"9","author":"Abreu","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib107","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"20","key":"10.1016\/j.canlet.2024.217279_bib108","article-title":"Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: a prospective observational study","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib109","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217279_bib110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217279_bib111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217279_bib112","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T13:44:48Z","timestamp":1731505488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524006748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":111,"alternative-id":["S0304383524006748"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217279","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217279"}}